Fares, Raafat
43  results:
Search for persons X
?
1

In silico modelling of stroke volume, cardiac output and sy..:

Champeroux, Pascal ; Thireau, Jérôme ; Le Guennec, Jean-Yves.
Journal of Pharmacological and Toxicological Methods.  127 (2024)  - p. 107512 , 2024
 
?
 
?
3

Simultaneous assessment of central nervous and respiratory ..:

Fares, Raafat ; Champéroux, Pascal
Journal of Pharmacological and Toxicological Methods.  121 (2023)  - p. 107268 , 2023
 
?
4

Contribution of haemodynamic side effects and associated au..:

Champéroux, Pascal ; Fares, Raafat ; Bastogne, Thierry...
British Journal of Pharmacology.  179 (2022)  18 - p. 4549-4562 , 2022
 
?
5

Non invasive jacketed telemetry in socially-housed rats for..:

Fares, Raafat ; Flénet, Timothé ; Vial, Jonathan...
Journal of Pharmacological and Toxicological Methods.  117 (2022)  - p. 107195 , 2022
 
?
8

Implementation of DSI FinePointe® whole body plethysmograph..:

Fares, Raafat ; Bory, Christophe ; Valgalier, Christophe.
Journal of Pharmacological and Toxicological Methods.  99 (2019)  - p. 106595 , 2019
 
?
9

Contributors:

, In: Models of Seizures and Epilepsy,
Aiba, Isamu ; Andrade, Pedro ; Angamo, Eskedar A.... - p. xvii-xxi , 2017
 
?
 
?
13

Optimal Neuroprotection by Erythropoietin Requires Elevated..:

Sanchez, Pascal E. ; Fares, Raafat P. ; Risso, Jean-Jacques...
Proceedings of the National Academy of Sciences of the United States of America.  106 (2009)  24 - p. 9848-9853 , 2009
 
?
14

Optimal neuroprotection by erythropoietin requires elevated..:

Sanchez, Pascal E. ; Fares, Raafat P. ; Risso, Jean-Jacques...
Proceedings of the National Academy of Sciences.  106 (2009)  24 - p. 9848-9853 , 2009
 
1-15